In this talk, Dr. Rao (VP Partnerships and Clinical Affairs) talks about the application of ClaretBio's flagship library preparation method SRSLY in cfDNA fragmentomics. This field as emerged as the cutting edge of liquid biopsy based biomarker discover where fragmentation patterns - including cfDNA length and end-motifs can potentially be used in agnostic cancer diagnosis with low-depth DNA sequencing.
PMWC 2025 - ClaretBio Showcase Presentation